Results 161 to 170 of about 26,122 (235)

Immuno-Inflammatory Profiling and Complement Activation in Fabry Disease: A Cross-Sectional Study. [PDF]

Int J Mol Sci
Peña-Rodríguez M, Bara-Ledesma N, Fabregate M, Morales Conejo M, Domínguez-Rodríguez F, Merino-Ortiz B, Stanescu S, Ruiz-Sala P, González García A, Belanger-Quintana A, López-Rodríguez M.   +10 more
europepmc   +1 more source

Concurrent fabry disease and monoclonal gammopathy of renal significance: a case report. [PDF]

BMC Nephrol
Li XY, Chen QN, Fang JN, Zeng ZC, Pan Y.
europepmc   +1 more source

Semaglutide treatment in MOSH is associated with altered DNA methylation patterns of genes related to glycolipid metabolism. [PDF]

Sci Rep
Guo Y, Su J, Shen L, Ding C, Wen Y, Li Z, Li F.   +6 more
europepmc   +1 more source

Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology. [PDF]

Dis Model Mech
Elsaid H, Furriol J, Eikrem Ø, Tøndel C, Svarstad E.   +4 more
europepmc   +1 more source

Bioactive Glycosphingolipids

Journal of Japan Oil Chemists' Society, 1991
openaire   +2 more sources

Metabolomic and inflammatory signatures in congenital hypothyroidism: a longitudinal analysis of levothyroxine response. [PDF]

Front Endocrinol (Lausanne)
Vela-Amieva M, Ibarra-González I, Calzada León R, Ruiz-Reyes ML, Constantini ME, Guillén-López S, López-Mejía L, Luna-Nequiz MC, Carrillo-Nieto RI, Fernández-Lainez C.   +9 more
europepmc   +1 more source

Rapid Progression of Coronary Disease in Fabry Disease: Vulnerable Plaque by Intravascular Ultrasound. [PDF]

JACC Case Rep
Li W, Zhao C, Liu M.
europepmc   +1 more source

Mitochondrial Quality Control Imbalance in the Heterogeneity of Parkinson's Disease: From Selective Vulnerability to Stratified Transformation. [PDF]

Int J Mol Sci
Chen Y, Wang C.
europepmc   +1 more source

Sphingolipid Metabolism: A Pathological Hub Linking Lipid Dysregulation and Chronic Inflammation in Atherosclerotic Cardiovascular Disease. [PDF]

J Inflamm Res
Wang S, Dong Y, Li X, Dong R, Jing L.
europepmc   +1 more source

UGCG and the glycosphingolipid rheostat: a metabolic checkpoint governing immune activation and tumor immune evasion. [PDF]

Signal Transduct Target Ther
Chen S, Wang X, Jounaidi Y.
europepmc   +1 more source